Calyx Bio-Ventures (CYX.H) Financial Statements
Calyx Bio-Ventures Financial Overview
Calyx Bio-Ventures's market cap is currently $947.82K. The company's EPS TTM is ―; its P/E ratio is ―; Calyx Bio-Ventures has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 18 | Dec 17 | Dec 16 | Dec 15 | Dec 14 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | $ 2.40K | $ 54.05K | $ 61.14K | $ 33.05K | ― |
| Operating Income | $ -796.00K | $ -1.06M | $ -694.83K | $ -450.99K | $ -568.28K |
| EBITDA | $ -1.62M | $ -918.45K | $ -556.69K | $ -39.17K | $ -513.60K |
| Net Income | $ -2.49M | $ -1.45M | $ -696.34K | $ -151.85K | $ -526.99K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 666.20K | $ 2.33M | $ 877.37K | $ 334.54K | $ 336.68K |
| Total Debt | $ 0.00 | $ 52.00K | $ 141.30K | $ 0.00 | $ 0.00 |
| Net Debt | $ -726.00 | $ -375.72K | $ -47.35K | $ -7.58K | $ -17.08K |
| Total Liabilities | $ 801.39K | $ 710.78K | $ 191.43K | $ 45.60K | $ 81.92K |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | $ -593.53K | $ -863.74K | $ -220.36K | $ -300.24K | $ -480.46K |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD
